According to The Block, there are currently two exchange-traded fund applications tied to the INJ token. One application is from 21Shares for the Injective ETF, and another comes from Canary Staked INJ ETF. The filings indicate ongoing review by regulatory authorities in the United States. Eric Chen, CEO of Injective Protocol, previously indicated expectations that U.S.-based INJ-related ETFs could launch before 2027. No timeline or confirmation has been provided for either application’s approval or launch date.
